SEH1L

Across TCGA pan-cancer cohorts, SEH1L Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SEH1L data layer compared with 27 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher SEH1L Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SEH1L expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

ESCA and UCEC are the cancer types where SEH1L Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.136	0.703	<.001	24	view →
UCEC	DFS	Median	All	1.000	0.830	.023	14	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

SEH1L–ESCA (OS)

Open the ESCA breakdown →